Product References
Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer.
Immunology
Xia J,Xie Z,Niu G,Lu Z,Wang Z,Xing Y,Ren J,Hu Z,Hong R,Cao Z,Han S,Chu Y,Liu R,Ke C
Published figure using CXCL13 polyclonal antibody (Product # PA5-28827) in Immunohistochemistry
Sun Jan 01 00:00:00 UTC 2023
CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn.
Journal of neuroinflammation
Wang J,Yin C,Pan Y,Yang Y,Li W,Ni H,Liu B,Nie H,Xu R,Wei H,Zhang Y,Li Y,Hu Q,Tai Y,Shao X,Fang J,Liu B
PA5-28827 was used in Immunohistochemistry (Frozen) to demonstrate a previously unidentified role of CXCL13/CXCR5 signaling in mediating spinal neuroinflammation and mechanical pain in an animal model of CRPS-I. Our work suggests that targeting CXCL13/CXCR5 pathway may lead to novel therapeutic approaches for CRPS-I. © 2023.
Mon May 08 00:00:00 UTC 2023
CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn.
Journal of neuroinflammation
Wang J,Yin C,Pan Y,Yang Y,Li W,Ni H,Liu B,Nie H,Xu R,Wei H,Zhang Y,Li Y,Hu Q,Tai Y,Shao X,Fang J,Liu B
PA5-28827 was used in Immunohistochemistry (Frozen) to demonstrate a previously unidentified role of CXCL13/CXCR5 signaling in mediating spinal neuroinflammation and mechanical pain in an animal model of CRPS-I. Our work suggests that targeting CXCL13/CXCR5 pathway may lead to novel therapeutic approaches for CRPS-I. © 2023.
Mon May 08 00:00:00 UTC 2023
CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn.
Journal of neuroinflammation
Wang J,Yin C,Pan Y,Yang Y,Li W,Ni H,Liu B,Nie H,Xu R,Wei H,Zhang Y,Li Y,Hu Q,Tai Y,Shao X,Fang J,Liu B
PA5-28827 was used in Immunohistochemistry (Frozen) to demonstrate a previously unidentified role of CXCL13/CXCR5 signaling in mediating spinal neuroinflammation and mechanical pain in an animal model of CRPS-I. Our work suggests that targeting CXCL13/CXCR5 pathway may lead to novel therapeutic approaches for CRPS-I. © 2023.
Mon May 08 00:00:00 UTC 2023
Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer.
Oncology letters
Luo X,Tai J,Zhao Y,Zhao P,Sun D,Wang L
PA5-28827 was used in Immunohistochemistry to assess the correlation of C-X-C motif chemokine ligand (CXCL)1, CXCL2, CXCL8, CXCL13 and CXCL14 with clinicopathological features and survival profile in patients with colorectal cancer (CRC).
Sat Oct 01 00:00:00 UTC 2022
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
Oncoimmunology
Jin K,Cao Y,Gu Y,Fang H,Fei Y,Wang J,Liu X,Lv K,He X,Lin C,Liu H,Li H,He H,Li R,Zhang H,Xu J
PA5-28827 was used in Immunohistochemistry to demonstrate that intratumoral CXCL13+CD8+ T cells infiltration could be an independent prognostic and predictive marker for gastric cancer patients, and might be a potential immunotherapeutic target in gastric cancer.
Tue Apr 27 00:00:00 UTC 2021
Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients.
Oncoimmunology
Jin K,Cao Y,Gu Y,Fang H,Fei Y,Wang J,Liu X,Lv K,He X,Lin C,Liu H,Li H,He H,Li R,Zhang H,Xu J
PA5-28827 was used in Immunohistochemistry to demonstrate that intratumoral CXCL13+CD8+ T cells infiltration could be an independent prognostic and predictive marker for gastric cancer patients, and might be a potential immunotherapeutic target in gastric cancer.
Tue Apr 27 00:00:00 UTC 2021